RSBAReturn Stacked Bonds & Merger Arbitrage ETF
Seeks long-term capital appreciation.
By Return stacked ETFs · Launched 2024
Annual Cost
1.01%
#4,997 of 5,562 · expensive
Fund Size
$48M
#3,607 of 5,562 · mid-size
Return (1Y)Goal
+4.2%
Track Record
1 year
#4,021 of 5,562 · young
Performance
Total-return NAV · USDGrowth of $10,000
$10,391+3.9%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 95.3% of fundconcentrated
First American Government Obli
30.4%
Chart Industries Inc
12.5%
Avidity Biosciences Inc
12.4%
Exact Sciences Corp
12.4%
Brighthouse Financial Inc
12.4%
Penumbra Inc
4.8%
Confluent Inc
4.8%
Cantaloupe Inc
4.6%
BioCryst Pharmaceuticals Inc
0.9%
N/A
0.0%
Asset allocation
Bonds
100.2%
Stocks
70.7%
Other
10.3%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
4.5%Low
Year-on-year price swings
Max drawdown
-2.8%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Bond profile
Credit ratings
US Government
100.2%
Where to buy
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Employs a hybrid approach with an actively managed Bond strategy investing in U.S. Treasury securities and a passively managed Merger Arbitrage strategy tracking the AlphaBeta Merger Arbitrage Index. Uses leverage to combine returns from both strategies.
- Inception date
- December 17, 2024
- Fund family
- Return stacked ETFs
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed RSBA. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19